Mark Wesbrock
Psychiatric/Mental Health · Gilbert, AZNPI 1003293606
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,153 and has fallen 94.0% since, to $69 in 2025. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$661
- Ironshore Pharmaceuticals Inc.$497
- Sunovion Pharmaceuticals Inc.$426
- Corium, LLC$268
- Johnson & Johnson$254
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$250
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,04999%
- Education$551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 46 | $661 |
| Ironshore Pharmaceuticals Inc. | 23 | $497 |
| Sunovion Pharmaceuticals Inc. | 22 | $426 |
| Corium, LLC | 15 | $268 |
| Johnson & Johnson | 12 | $254 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $250 |
| Lundbeck LLC | 14 | $247 |
| Tris Pharma Inc | 14 | $242 |
| Vanda Pharmaceuticals Inc. | 10 | $204 |
| Almatica Pharma LLC | 6 | $185 |
| Otsuka America Pharmaceutical, Inc. | 10 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $88 |
| Axsome Therapeutics, Inc. | 5 | $83 |
| Vertical Pharmaceuticals, LLC | 4 | $79 |
| Alkermes, Inc. | 4 | $79 |
| Merck | 3 | $50 |
| Bausch Health US, LLC | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Jazz Pharmaceuticals Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Neos Therapeutics, LP | 2 | $28 |
| Biogen | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $16 |
| Avion Pharmaceuticals | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $12 |
How this compares
$4,105 in reported general payments places this provider in the 90th percentile of 1,230 psychiatric/mental health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CymbaltaDuloxetine Hcl | 25 | $6,452 |
| Lamotrigine | 24 | $355 |
| Zolpidem Tartrate ErZolpidem Tartrate | 12 | $152 |
| Lorazepam | 16 | $83 |
| Alprazolam | 28 | $42 |
| Zolpidem Tartrate | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Gilbert
- Diane StrickerGilbert$281K
- Roya NayeriGilbert$15K
- Ann CaseyGilbert$7K
- Nicole LyonsGilbert$7K
- Landis StokumGilbert$7K
- Jeffrey ScottGilbert$7K
- Rachel EagerGilbert$7K
- Marcus DanielsGilbert$6K
- Sarah ButtlesGilbert$6K
- Melanie LaubGilbert$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.